1h Free Analyst Time
The global generic drugs market is forecasted to grow by USD 229.9 bn during 2025-2030, accelerating at a CAGR of 7.5% during the forecast period. The report on the global generic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by patent expirations on blockbuster pharmaceuticals, rising prevalence of chronic non-communicable diseases, institutional cost containment and generic substitution mandates.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global generic drugs market is segmented as below:
By Route Of Administration
- Oral
- Injectables
- Topical
- Inhalers
By Type
- Small-molecule generics
- Biosimilars
By Application
- Anti-infectives
- CNS
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global generic drugs market covers the following areas:
- Global generic drugs market sizing
- Global generic drugs market forecast
- Global generic drugs market industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ billion)
- Data Table on Global - Market size and forecast 2025-2030 ($ billion)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Generic Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Generic Drugs Market 2020 - 2024 ($ billion)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ billion)
- Historic Market Size - Type Segment 2020 - 2024 ($ billion)
- Historic Market Size - Application Segment 2020 - 2024 ($ billion)
- Historic Market Size - Geography Segment 2020 - 2024 ($ billion)
- Historic Market Size - Country Segment 2020 - 2024 ($ billion)
6 Qualitative Analysis
6.1 Impact of AI on Global Generic Drugs Market
6.2 Impact of Geopolitical Conflicts on Global Generic Drugs Market
6.2 Impact of Geopolitical Conflicts on Global Generic Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Route of Administration
8.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ billion)
- Data Table on Oral - Market size and forecast 2025-2030 ($ billion)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Injectables - Market size and forecast 2025-2030 ($ billion)
- Data Table on Injectables - Market size and forecast 2025-2030 ($ billion)
- Chart on Injectables - Year-over-year growth 2025-2030 (%)
- Data Table on Injectables - Year-over-year growth 2025-2030 (%)
- Chart on Topical - Market size and forecast 2025-2030 ($ billion)
- Data Table on Topical - Market size and forecast 2025-2030 ($ billion)
- Chart on Topical - Year-over-year growth 2025-2030 (%)
- Data Table on Topical - Year-over-year growth 2025-2030 (%)
- Chart on Inhalers - Market size and forecast 2025-2030 ($ billion)
- Data Table on Inhalers - Market size and forecast 2025-2030 ($ billion)
- Chart on Inhalers - Year-over-year growth 2025-2030 (%)
- Data Table on Inhalers - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ billion)
- Data Table on Market opportunity by Route of Administration ($ billion)
9 Market Segmentation by Type
9.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Small-molecule generics - Market size and forecast 2025-2030 ($ billion)
- Data Table on Small-molecule generics - Market size and forecast 2025-2030 ($ billion)
- Chart on Small-molecule generics - Year-over-year growth 2025-2030 (%)
- Data Table on Small-molecule generics - Year-over-year growth 2025-2030 (%)
- Chart on Biosimilars - Market size and forecast 2025-2030 ($ billion)
- Data Table on Biosimilars - Market size and forecast 2025-2030 ($ billion)
- Chart on Biosimilars - Year-over-year growth 2025-2030 (%)
- Data Table on Biosimilars - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)
10 Market Segmentation by Application
10.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Anti-infectives - Market size and forecast 2025-2030 ($ billion)
- Data Table on Anti-infectives - Market size and forecast 2025-2030 ($ billion)
- Chart on Anti-infectives - Year-over-year growth 2025-2030 (%)
- Data Table on Anti-infectives - Year-over-year growth 2025-2030 (%)
- Chart on CNS - Market size and forecast 2025-2030 ($ billion)
- Data Table on CNS - Market size and forecast 2025-2030 ($ billion)
- Chart on CNS - Year-over-year growth 2025-2030 (%)
- Data Table on CNS - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ billion)
- Data Table on Others - Market size and forecast 2025-2030 ($ billion)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ billion)
- Data Table on North America - Market size and forecast 2025-2030 ($ billion)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ billion)
- Data Table on US - Market size and forecast 2025-2030 ($ billion)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ billion)
- Data Table on Canada - Market size and forecast 2025-2030 ($ billion)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ billion)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ billion)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ billion)
- Data Table on Europe - Market size and forecast 2025-2030 ($ billion)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ billion)
- Data Table on Germany - Market size and forecast 2025-2030 ($ billion)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ billion)
- Data Table on UK - Market size and forecast 2025-2030 ($ billion)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ billion)
- Data Table on France - Market size and forecast 2025-2030 ($ billion)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ billion)
- Data Table on Italy - Market size and forecast 2025-2030 ($ billion)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ billion)
- Data Table on Spain - Market size and forecast 2025-2030 ($ billion)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ billion)
- Data Table on Asia - Market size and forecast 2025-2030 ($ billion)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ billion)
- Data Table on China - Market size and forecast 2025-2030 ($ billion)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ billion)
- Data Table on India - Market size and forecast 2025-2030 ($ billion)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ billion)
- Data Table on Japan - Market size and forecast 2025-2030 ($ billion)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ billion)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ billion)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ billion)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ billion)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ billion)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ billion)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ billion)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ billion)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ billion)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ billion)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ billion)
- Data Table on UAE - Market size and forecast 2025-2030 ($ billion)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ billion)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ billion)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Chile - Market size and forecast 2025-2030 ($ billion)
- Data Table on Chile - Market size and forecast 2025-2030 ($ billion)
- Chart on Chile - Year-over-year growth 2025-2030 (%)
- Data Table on Chile - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ billion)
- Data Table on Israel - Market size and forecast 2025-2030 ($ billion)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Chart on Egypt - Market size and forecast 2025-2030 ($ billion)
- Data Table on Egypt - Market size and forecast 2025-2030 ($ billion)
- Chart on Egypt - Year-over-year growth 2025-2030 (%)
- Data Table on Egypt - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Patent expirations on blockbuster pharmaceuticals
- Rising prevalence of chronic non-communicable diseases
- Institutional cost containment and generic substitution mandates
- Price deflation and margin compression
- Supply chain concentration and raw material vulnerabilities
- Elevated regulatory oversight and quality compliance standards
- Impact of drivers and challenges in 2025 and 2030
- Strategic portfolio transition toward complex generics and differentiated injectables
- Acceleration of biosimilar commercialization and interchangeability standards
- Adoption of continuous manufacturing and digitalization in active pharmaceutical ingredient synthesis
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Alkem Laboratories Ltd. - Overview
- Alkem Laboratories Ltd. - Business segments
- Alkem Laboratories Ltd. - Key offerings
- Alkem Laboratories Ltd. - Segment focus
- SWOT
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Business segments
- Aurobindo Pharma Ltd. - Key news
- Aurobindo Pharma Ltd. - Key offerings
- Aurobindo Pharma Ltd. - Segment focus
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key news
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- SWOT
- Krka d.d. - Overview
- Krka d.d. - Business segments
- Krka d.d. - Key offerings
- Krka d.d. - Segment focus
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Sandoz Group AG - Overview
- Sandoz Group AG - Business segments
- Sandoz Group AG - Key news
- Sandoz Group AG - Key offerings
- Sandoz Group AG - Segment focus
- SWOT
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Business segments
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- Sun Pharmaceutical Industries - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Torrent Pharmaceuticals Ltd. - Overview
- Torrent Pharmaceuticals Ltd. - Product / Service
- Torrent Pharmaceuticals Ltd. - Key offerings
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by Application
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ billion)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ billion)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Generic Drugs Market 2020 - 2024 ($ billion)
Exhibit 26: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ billion)
Exhibit 27: Historic Market Size - Type Segment 2020 - 2024 ($ billion)
Exhibit 28: Historic Market Size - Application Segment 2020 - 2024 ($ billion)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ billion)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ billion)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 39: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Route of Administration
Exhibit 41: Data Table on Comparison by Route of Administration
Exhibit 42: Chart on Oral - Market size and forecast 2025-2030 ($ billion)
Exhibit 43: Data Table on Oral - Market size and forecast 2025-2030 ($ billion)
Exhibit 44: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Injectables - Market size and forecast 2025-2030 ($ billion)
Exhibit 47: Data Table on Injectables - Market size and forecast 2025-2030 ($ billion)
Exhibit 48: Chart on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Topical - Market size and forecast 2025-2030 ($ billion)
Exhibit 51: Data Table on Topical - Market size and forecast 2025-2030 ($ billion)
Exhibit 52: Chart on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Inhalers - Market size and forecast 2025-2030 ($ billion)
Exhibit 55: Data Table on Inhalers - Market size and forecast 2025-2030 ($ billion)
Exhibit 56: Chart on Inhalers - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Inhalers - Year-over-year growth 2025-2030 (%)
Exhibit 58: Market opportunity by Route of Administration ($ billion)
Exhibit 59: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibit 60: Chart on Type - Market share 2025-2030 (%)
Exhibit 61: Data Table on Type - Market share 2025-2030 (%)
Exhibit 62: Chart on Comparison by Type
Exhibit 63: Data Table on Comparison by Type
Exhibit 64: Chart on Small-molecule generics - Market size and forecast 2025-2030 ($ billion)
Exhibit 65: Data Table on Small-molecule generics - Market size and forecast 2025-2030 ($ billion)
Exhibit 66: Chart on Small-molecule generics - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Small-molecule generics - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Biosimilars - Market size and forecast 2025-2030 ($ billion)
Exhibit 69: Data Table on Biosimilars - Market size and forecast 2025-2030 ($ billion)
Exhibit 70: Chart on Biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Type ($ billion)
Exhibit 73: Data Table on Market opportunity by Type ($ billion)
Exhibit 74: Chart on Application - Market share 2025-2030 (%)
Exhibit 75: Data Table on Application - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Application
Exhibit 77: Data Table on Comparison by Application
Exhibit 78: Chart on Anti-infectives - Market size and forecast 2025-2030 ($ billion)
Exhibit 79: Data Table on Anti-infectives - Market size and forecast 2025-2030 ($ billion)
Exhibit 80: Chart on Anti-infectives - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Anti-infectives - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on CNS - Market size and forecast 2025-2030 ($ billion)
Exhibit 83: Data Table on CNS - Market size and forecast 2025-2030 ($ billion)
Exhibit 84: Chart on CNS - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on CNS - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Others - Market size and forecast 2025-2030 ($ billion)
Exhibit 87: Data Table on Others - Market size and forecast 2025-2030 ($ billion)
Exhibit 88: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 90: Market opportunity by Application ($ billion)
Exhibit 91: Data Table on Market opportunity by Application ($ billion)
Exhibit 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 93: Chart on Market share by geography 2025-2030 (%)
Exhibit 94: Data Table on Market share by geography 2025-2030 (%)
Exhibit 95: Chart on Geographic comparison
Exhibit 96: Data Table on Geographic comparison
Exhibit 97: Chart on North America - Market size and forecast 2025-2030 ($ billion)
Exhibit 98: Data Table on North America - Market size and forecast 2025-2030 ($ billion)
Exhibit 99: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 100: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 101: Chart on Regional Comparison - North America
Exhibit 102: Data Table on Regional Comparison - North America
Exhibit 103: Chart on US - Market size and forecast 2025-2030 ($ billion)
Exhibit 104: Data Table on US - Market size and forecast 2025-2030 ($ billion)
Exhibit 105: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Canada - Market size and forecast 2025-2030 ($ billion)
Exhibit 108: Data Table on Canada - Market size and forecast 2025-2030 ($ billion)
Exhibit 109: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Mexico - Market size and forecast 2025-2030 ($ billion)
Exhibit 112: Data Table on Mexico - Market size and forecast 2025-2030 ($ billion)
Exhibit 113: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Europe - Market size and forecast 2025-2030 ($ billion)
Exhibit 116: Data Table on Europe - Market size and forecast 2025-2030 ($ billion)
Exhibit 117: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Regional Comparison - Europe
Exhibit 120: Data Table on Regional Comparison - Europe
Exhibit 121: Chart on Germany - Market size and forecast 2025-2030 ($ billion)
Exhibit 122: Data Table on Germany - Market size and forecast 2025-2030 ($ billion)
Exhibit 123: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on UK - Market size and forecast 2025-2030 ($ billion)
Exhibit 126: Data Table on UK - Market size and forecast 2025-2030 ($ billion)
Exhibit 127: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on France - Market size and forecast 2025-2030 ($ billion)
Exhibit 130: Data Table on France - Market size and forecast 2025-2030 ($ billion)
Exhibit 131: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Italy - Market size and forecast 2025-2030 ($ billion)
Exhibit 134: Data Table on Italy - Market size and forecast 2025-2030 ($ billion)
Exhibit 135: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2025-2030 ($ billion)
Exhibit 138: Data Table on Spain - Market size and forecast 2025-2030 ($ billion)
Exhibit 139: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on The Netherlands - Market size and forecast 2025-2030 ($ billion)
Exhibit 142: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ billion)
Exhibit 143: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2025-2030 ($ billion)
Exhibit 146: Data Table on Asia - Market size and forecast 2025-2030 ($ billion)
Exhibit 147: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on China - Market size and forecast 2025-2030 ($ billion)
Exhibit 152: Data Table on China - Market size and forecast 2025-2030 ($ billion)
Exhibit 153: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on India - Market size and forecast 2025-2030 ($ billion)
Exhibit 156: Data Table on India - Market size and forecast 2025-2030 ($ billion)
Exhibit 157: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Japan - Market size and forecast 2025-2030 ($ billion)
Exhibit 160: Data Table on Japan - Market size and forecast 2025-2030 ($ billion)
Exhibit 161: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2025-2030 ($ billion)
Exhibit 164: Data Table on South Korea - Market size and forecast 2025-2030 ($ billion)
Exhibit 165: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Indonesia - Market size and forecast 2025-2030 ($ billion)
Exhibit 168: Data Table on Indonesia - Market size and forecast 2025-2030 ($ billion)
Exhibit 169: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2025-2030 ($ billion)
Exhibit 172: Data Table on Thailand - Market size and forecast 2025-2030 ($ billion)
Exhibit 173: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ billion)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ billion)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Brazil - Market size and forecast 2025-2030 ($ billion)
Exhibit 182: Data Table on Brazil - Market size and forecast 2025-2030 ($ billion)
Exhibit 183: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on South Africa - Market size and forecast 2025-2030 ($ billion)
Exhibit 186: Data Table on South Africa - Market size and forecast 2025-2030 ($ billion)
Exhibit 187: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ billion)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ billion)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ billion)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ billion)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Argentina - Market size and forecast 2025-2030 ($ billion)
Exhibit 198: Data Table on Argentina - Market size and forecast 2025-2030 ($ billion)
Exhibit 199: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Chile - Market size and forecast 2025-2030 ($ billion)
Exhibit 202: Data Table on Chile - Market size and forecast 2025-2030 ($ billion)
Exhibit 203: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2025-2030 ($ billion)
Exhibit 206: Data Table on Israel - Market size and forecast 2025-2030 ($ billion)
Exhibit 207: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Egypt - Market size and forecast 2025-2030 ($ billion)
Exhibit 210: Data Table on Egypt - Market size and forecast 2025-2030 ($ billion)
Exhibit 211: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 213: Market opportunity by geography ($ billion)
Exhibit 214: Data Tables on Market opportunity by geography ($ billion)
Exhibit 215: Impact of drivers and challenges in 2025 and 2030
Exhibit 216: Overview on criticality of inputs and factors of differentiation
Exhibit 217: Overview on factors of disruption
Exhibit 218: Impact of key risks on business
Exhibit 219: Companies covered
Exhibit 220: Company ranking index
Exhibit 221: Matrix on companies position and classification
Exhibit 222: Alkem Laboratories Ltd. - Overview
Exhibit 223: Alkem Laboratories Ltd. - Business segments
Exhibit 224: Alkem Laboratories Ltd. - Key offerings
Exhibit 225: Alkem Laboratories Ltd. - Segment focus
Exhibit 226: SWOT
Exhibit 227: Amneal Pharmaceuticals Inc. - Overview
Exhibit 228: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 229: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 230: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 231: SWOT
Exhibit 232: Aurobindo Pharma Ltd. - Overview
Exhibit 233: Aurobindo Pharma Ltd. - Business segments
Exhibit 234: Aurobindo Pharma Ltd. - Key news
Exhibit 235: Aurobindo Pharma Ltd. - Key offerings
Exhibit 236: Aurobindo Pharma Ltd. - Segment focus
Exhibit 237: SWOT
Exhibit 238: Cipla Inc. - Overview
Exhibit 239: Cipla Inc. - Business segments
Exhibit 240: Cipla Inc. - Key news
Exhibit 241: Cipla Inc. - Key offerings
Exhibit 242: Cipla Inc. - Segment focus
Exhibit 243: SWOT
Exhibit 244: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 245: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 246: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 247: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 248: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 249: SWOT
Exhibit 250: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 251: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 252: Glenmark Pharmaceuticals Ltd. - Key news
Exhibit 253: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 254: SWOT
Exhibit 255: Hikma Pharmaceuticals Plc - Overview
Exhibit 256: Hikma Pharmaceuticals Plc - Business segments
Exhibit 257: Hikma Pharmaceuticals Plc - Key news
Exhibit 258: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 259: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 260: SWOT
Exhibit 261: Krka d.d. - Overview
Exhibit 262: Krka d.d. - Business segments
Exhibit 263: Krka d.d. - Key offerings
Exhibit 264: Krka d.d. - Segment focus
Exhibit 265: SWOT
Exhibit 266: Lupin Ltd. - Overview
Exhibit 267: Lupin Ltd. - Business segments
Exhibit 268: Lupin Ltd. - Key news
Exhibit 269: Lupin Ltd. - Key offerings
Exhibit 270: Lupin Ltd. - Segment focus
Exhibit 271: SWOT
Exhibit 272: Sandoz Group AG - Overview
Exhibit 273: Sandoz Group AG - Business segments
Exhibit 274: Sandoz Group AG - Key news
Exhibit 275: Sandoz Group AG - Key offerings
Exhibit 276: Sandoz Group AG - Segment focus
Exhibit 277: SWOT
Exhibit 278: Sun Pharmaceutical Industries - Overview
Exhibit 279: Sun Pharmaceutical Industries - Business segments
Exhibit 280: Sun Pharmaceutical Industries - Key news
Exhibit 281: Sun Pharmaceutical Industries - Key offerings
Exhibit 282: Sun Pharmaceutical Industries - Segment focus
Exhibit 283: SWOT
Exhibit 284: Teva Pharmaceutical Ltd. - Overview
Exhibit 285: Teva Pharmaceutical Ltd. - Business segments
Exhibit 286: Teva Pharmaceutical Ltd. - Key news
Exhibit 287: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 288: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 289: SWOT
Exhibit 290: Torrent Pharmaceuticals Ltd. - Overview
Exhibit 291: Torrent Pharmaceuticals Ltd. - Product / Service
Exhibit 292: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibit 293: SWOT
Exhibit 294: Viatris Inc. - Overview
Exhibit 295: Viatris Inc. - Business segments
Exhibit 296: Viatris Inc. - Key news
Exhibit 297: Viatris Inc. - Key offerings
Exhibit 298: Viatris Inc. - Segment focus
Exhibit 299: SWOT
Exhibit 300: Zydus Lifesciences Ltd. - Overview
Exhibit 301: Zydus Lifesciences Ltd. - Business segments
Exhibit 302: Zydus Lifesciences Ltd. - Key news
Exhibit 303: Zydus Lifesciences Ltd. - Key offerings
Exhibit 304: Zydus Lifesciences Ltd. - Segment focus
Exhibit 305: SWOT
Exhibit 306: Inclusions checklist
Exhibit 307: Exclusions checklist
Exhibit 308: Currency conversion rates for US$
Exhibit 309: Research methodology
Exhibit 310: Information sources
Exhibit 311: Data validation
Exhibit 312: Validation techniques employed for market sizing
Exhibit 313: Data synthesis
Exhibit 314: 360 degree market analysis
Exhibit 315: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by Application
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ billion)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ billion)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Generic Drugs Market 2020 - 2024 ($ billion)
Exhibit 26: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ billion)
Exhibit 27: Historic Market Size - Type Segment 2020 - 2024 ($ billion)
Exhibit 28: Historic Market Size - Application Segment 2020 - 2024 ($ billion)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ billion)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ billion)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 39: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Route of Administration
Exhibit 41: Data Table on Comparison by Route of Administration
Exhibit 42: Chart on Oral - Market size and forecast 2025-2030 ($ billion)
Exhibit 43: Data Table on Oral - Market size and forecast 2025-2030 ($ billion)
Exhibit 44: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Injectables - Market size and forecast 2025-2030 ($ billion)
Exhibit 47: Data Table on Injectables - Market size and forecast 2025-2030 ($ billion)
Exhibit 48: Chart on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Topical - Market size and forecast 2025-2030 ($ billion)
Exhibit 51: Data Table on Topical - Market size and forecast 2025-2030 ($ billion)
Exhibit 52: Chart on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Inhalers - Market size and forecast 2025-2030 ($ billion)
Exhibit 55: Data Table on Inhalers - Market size and forecast 2025-2030 ($ billion)
Exhibit 56: Chart on Inhalers - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Inhalers - Year-over-year growth 2025-2030 (%)
Exhibit 58: Market opportunity by Route of Administration ($ billion)
Exhibit 59: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibit 60: Chart on Type - Market share 2025-2030 (%)
Exhibit 61: Data Table on Type - Market share 2025-2030 (%)
Exhibit 62: Chart on Comparison by Type
Exhibit 63: Data Table on Comparison by Type
Exhibit 64: Chart on Small-molecule generics - Market size and forecast 2025-2030 ($ billion)
Exhibit 65: Data Table on Small-molecule generics - Market size and forecast 2025-2030 ($ billion)
Exhibit 66: Chart on Small-molecule generics - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Small-molecule generics - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Biosimilars - Market size and forecast 2025-2030 ($ billion)
Exhibit 69: Data Table on Biosimilars - Market size and forecast 2025-2030 ($ billion)
Exhibit 70: Chart on Biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Type ($ billion)
Exhibit 73: Data Table on Market opportunity by Type ($ billion)
Exhibit 74: Chart on Application - Market share 2025-2030 (%)
Exhibit 75: Data Table on Application - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Application
Exhibit 77: Data Table on Comparison by Application
Exhibit 78: Chart on Anti-infectives - Market size and forecast 2025-2030 ($ billion)
Exhibit 79: Data Table on Anti-infectives - Market size and forecast 2025-2030 ($ billion)
Exhibit 80: Chart on Anti-infectives - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Anti-infectives - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on CNS - Market size and forecast 2025-2030 ($ billion)
Exhibit 83: Data Table on CNS - Market size and forecast 2025-2030 ($ billion)
Exhibit 84: Chart on CNS - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on CNS - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Others - Market size and forecast 2025-2030 ($ billion)
Exhibit 87: Data Table on Others - Market size and forecast 2025-2030 ($ billion)
Exhibit 88: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 90: Market opportunity by Application ($ billion)
Exhibit 91: Data Table on Market opportunity by Application ($ billion)
Exhibit 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 93: Chart on Market share by geography 2025-2030 (%)
Exhibit 94: Data Table on Market share by geography 2025-2030 (%)
Exhibit 95: Chart on Geographic comparison
Exhibit 96: Data Table on Geographic comparison
Exhibit 97: Chart on North America - Market size and forecast 2025-2030 ($ billion)
Exhibit 98: Data Table on North America - Market size and forecast 2025-2030 ($ billion)
Exhibit 99: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 100: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 101: Chart on Regional Comparison - North America
Exhibit 102: Data Table on Regional Comparison - North America
Exhibit 103: Chart on US - Market size and forecast 2025-2030 ($ billion)
Exhibit 104: Data Table on US - Market size and forecast 2025-2030 ($ billion)
Exhibit 105: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Canada - Market size and forecast 2025-2030 ($ billion)
Exhibit 108: Data Table on Canada - Market size and forecast 2025-2030 ($ billion)
Exhibit 109: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Mexico - Market size and forecast 2025-2030 ($ billion)
Exhibit 112: Data Table on Mexico - Market size and forecast 2025-2030 ($ billion)
Exhibit 113: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Europe - Market size and forecast 2025-2030 ($ billion)
Exhibit 116: Data Table on Europe - Market size and forecast 2025-2030 ($ billion)
Exhibit 117: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Regional Comparison - Europe
Exhibit 120: Data Table on Regional Comparison - Europe
Exhibit 121: Chart on Germany - Market size and forecast 2025-2030 ($ billion)
Exhibit 122: Data Table on Germany - Market size and forecast 2025-2030 ($ billion)
Exhibit 123: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on UK - Market size and forecast 2025-2030 ($ billion)
Exhibit 126: Data Table on UK - Market size and forecast 2025-2030 ($ billion)
Exhibit 127: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on France - Market size and forecast 2025-2030 ($ billion)
Exhibit 130: Data Table on France - Market size and forecast 2025-2030 ($ billion)
Exhibit 131: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Italy - Market size and forecast 2025-2030 ($ billion)
Exhibit 134: Data Table on Italy - Market size and forecast 2025-2030 ($ billion)
Exhibit 135: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2025-2030 ($ billion)
Exhibit 138: Data Table on Spain - Market size and forecast 2025-2030 ($ billion)
Exhibit 139: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on The Netherlands - Market size and forecast 2025-2030 ($ billion)
Exhibit 142: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ billion)
Exhibit 143: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2025-2030 ($ billion)
Exhibit 146: Data Table on Asia - Market size and forecast 2025-2030 ($ billion)
Exhibit 147: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on China - Market size and forecast 2025-2030 ($ billion)
Exhibit 152: Data Table on China - Market size and forecast 2025-2030 ($ billion)
Exhibit 153: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on India - Market size and forecast 2025-2030 ($ billion)
Exhibit 156: Data Table on India - Market size and forecast 2025-2030 ($ billion)
Exhibit 157: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Japan - Market size and forecast 2025-2030 ($ billion)
Exhibit 160: Data Table on Japan - Market size and forecast 2025-2030 ($ billion)
Exhibit 161: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2025-2030 ($ billion)
Exhibit 164: Data Table on South Korea - Market size and forecast 2025-2030 ($ billion)
Exhibit 165: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Indonesia - Market size and forecast 2025-2030 ($ billion)
Exhibit 168: Data Table on Indonesia - Market size and forecast 2025-2030 ($ billion)
Exhibit 169: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2025-2030 ($ billion)
Exhibit 172: Data Table on Thailand - Market size and forecast 2025-2030 ($ billion)
Exhibit 173: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ billion)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ billion)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Brazil - Market size and forecast 2025-2030 ($ billion)
Exhibit 182: Data Table on Brazil - Market size and forecast 2025-2030 ($ billion)
Exhibit 183: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on South Africa - Market size and forecast 2025-2030 ($ billion)
Exhibit 186: Data Table on South Africa - Market size and forecast 2025-2030 ($ billion)
Exhibit 187: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ billion)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ billion)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ billion)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ billion)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Argentina - Market size and forecast 2025-2030 ($ billion)
Exhibit 198: Data Table on Argentina - Market size and forecast 2025-2030 ($ billion)
Exhibit 199: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Chile - Market size and forecast 2025-2030 ($ billion)
Exhibit 202: Data Table on Chile - Market size and forecast 2025-2030 ($ billion)
Exhibit 203: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2025-2030 ($ billion)
Exhibit 206: Data Table on Israel - Market size and forecast 2025-2030 ($ billion)
Exhibit 207: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Egypt - Market size and forecast 2025-2030 ($ billion)
Exhibit 210: Data Table on Egypt - Market size and forecast 2025-2030 ($ billion)
Exhibit 211: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 213: Market opportunity by geography ($ billion)
Exhibit 214: Data Tables on Market opportunity by geography ($ billion)
Exhibit 215: Impact of drivers and challenges in 2025 and 2030
Exhibit 216: Overview on criticality of inputs and factors of differentiation
Exhibit 217: Overview on factors of disruption
Exhibit 218: Impact of key risks on business
Exhibit 219: Companies covered
Exhibit 220: Company ranking index
Exhibit 221: Matrix on companies position and classification
Exhibit 222: Alkem Laboratories Ltd. - Overview
Exhibit 223: Alkem Laboratories Ltd. - Business segments
Exhibit 224: Alkem Laboratories Ltd. - Key offerings
Exhibit 225: Alkem Laboratories Ltd. - Segment focus
Exhibit 226: SWOT
Exhibit 227: Amneal Pharmaceuticals Inc. - Overview
Exhibit 228: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 229: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 230: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 231: SWOT
Exhibit 232: Aurobindo Pharma Ltd. - Overview
Exhibit 233: Aurobindo Pharma Ltd. - Business segments
Exhibit 234: Aurobindo Pharma Ltd. - Key news
Exhibit 235: Aurobindo Pharma Ltd. - Key offerings
Exhibit 236: Aurobindo Pharma Ltd. - Segment focus
Exhibit 237: SWOT
Exhibit 238: Cipla Inc. - Overview
Exhibit 239: Cipla Inc. - Business segments
Exhibit 240: Cipla Inc. - Key news
Exhibit 241: Cipla Inc. - Key offerings
Exhibit 242: Cipla Inc. - Segment focus
Exhibit 243: SWOT
Exhibit 244: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 245: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 246: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 247: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 248: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 249: SWOT
Exhibit 250: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 251: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 252: Glenmark Pharmaceuticals Ltd. - Key news
Exhibit 253: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 254: SWOT
Exhibit 255: Hikma Pharmaceuticals Plc - Overview
Exhibit 256: Hikma Pharmaceuticals Plc - Business segments
Exhibit 257: Hikma Pharmaceuticals Plc - Key news
Exhibit 258: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 259: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 260: SWOT
Exhibit 261: Krka d.d. - Overview
Exhibit 262: Krka d.d. - Business segments
Exhibit 263: Krka d.d. - Key offerings
Exhibit 264: Krka d.d. - Segment focus
Exhibit 265: SWOT
Exhibit 266: Lupin Ltd. - Overview
Exhibit 267: Lupin Ltd. - Business segments
Exhibit 268: Lupin Ltd. - Key news
Exhibit 269: Lupin Ltd. - Key offerings
Exhibit 270: Lupin Ltd. - Segment focus
Exhibit 271: SWOT
Exhibit 272: Sandoz Group AG - Overview
Exhibit 273: Sandoz Group AG - Business segments
Exhibit 274: Sandoz Group AG - Key news
Exhibit 275: Sandoz Group AG - Key offerings
Exhibit 276: Sandoz Group AG - Segment focus
Exhibit 277: SWOT
Exhibit 278: Sun Pharmaceutical Industries - Overview
Exhibit 279: Sun Pharmaceutical Industries - Business segments
Exhibit 280: Sun Pharmaceutical Industries - Key news
Exhibit 281: Sun Pharmaceutical Industries - Key offerings
Exhibit 282: Sun Pharmaceutical Industries - Segment focus
Exhibit 283: SWOT
Exhibit 284: Teva Pharmaceutical Ltd. - Overview
Exhibit 285: Teva Pharmaceutical Ltd. - Business segments
Exhibit 286: Teva Pharmaceutical Ltd. - Key news
Exhibit 287: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 288: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 289: SWOT
Exhibit 290: Torrent Pharmaceuticals Ltd. - Overview
Exhibit 291: Torrent Pharmaceuticals Ltd. - Product / Service
Exhibit 292: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibit 293: SWOT
Exhibit 294: Viatris Inc. - Overview
Exhibit 295: Viatris Inc. - Business segments
Exhibit 296: Viatris Inc. - Key news
Exhibit 297: Viatris Inc. - Key offerings
Exhibit 298: Viatris Inc. - Segment focus
Exhibit 299: SWOT
Exhibit 300: Zydus Lifesciences Ltd. - Overview
Exhibit 301: Zydus Lifesciences Ltd. - Business segments
Exhibit 302: Zydus Lifesciences Ltd. - Key news
Exhibit 303: Zydus Lifesciences Ltd. - Key offerings
Exhibit 304: Zydus Lifesciences Ltd. - Segment focus
Exhibit 305: SWOT
Exhibit 306: Inclusions checklist
Exhibit 307: Exclusions checklist
Exhibit 308: Currency conversion rates for US$
Exhibit 309: Research methodology
Exhibit 310: Information sources
Exhibit 311: Data validation
Exhibit 312: Validation techniques employed for market sizing
Exhibit 313: Data synthesis
Exhibit 314: 360 degree market analysis
Exhibit 315: List of abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alkem Laboratories Ltd.
- Alvogen Inc
- Amneal Pharmaceuticals Inc.
- Apotex Inc.
- Aspen Pharmacare Ltd.
- Aurobindo Pharma Ltd.
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- Fresenius Kabi AG
- Glenmark Pharmaceuticals Ltd.
- Hetero Labs Ltd.
- Hikma Pharmaceuticals Plc
- Krka d.d.
- Lupin Ltd.
- Sandoz Group AG
- Sun Pharmaceutical Industries
- Teva Pharmaceutical Ltd.
- Torrent Pharmaceuticals Ltd.
- Viatris Inc.
- Zydus Lifesciences Ltd.
